Company Overview
About IQVIA
IQVIA Holdings is the world's largest contract research organization (CRO) and leading provider of healthcare data and analytics, formed in 2016 through the $9 billion merger of IMS Health (healthcare information and technology services) and Quintiles Transnational Holdings (clinical research services), headquartered in Durham, North Carolina and trading on NYSE (IQV). The company generated approximately $15.2 billion in revenues for FY2024 under CEO Ari Bousbib, who led both legacy companies and has driven the combined entity to become an indispensable partner to pharmaceutical and biotechnology companies across the drug development lifecycle—from clinical trial design and execution through regulatory approval and commercial launch analytics.
Business Model & Competitive Advantage
IQVIA's unique competitive moat is its healthcare data ecosystem: the company aggregates and manages one of the world's largest collections of real-world evidence, including de-identified patient-level claims data, electronic health records, prescription dispensing data, and hospital utilization records covering over 1 billion patient records globally. This proprietary data infrastructure powers market research and commercial analytics for pharma customers tracking drug sales performance, competitor market share, prescription trends, and treatment pathway optimization. The Technology & Analytics Solutions (TAS) segment provides this data platform alongside software and managed services, while the Research & Development Solutions (RDS) segment manages clinical trials from Phase I through Phase IV using IQVIA's global clinical infrastructure of 90,000+ investigators and 7,000 technology applications.
Competitive Landscape 2025–2026
In 2025-2026, IQVIA benefits from record levels of pharmaceutical R&D investment—driven by the GLP-1 obesity drug boom (Novo Nordisk, Eli Lilly), oncology pipeline expansion, and mRNA technology applications beyond COVID—as drug developers require both CRO capacity and real-world evidence to support regulatory submissions and commercial strategies. The CRO industry consolidation has left IQVIA competing primarily with ICON plc (merged with PRA Health Sciences), Syneos Health (acquired by private equity in 2023), and Covance (LabCorp CDS division), with smaller niche CROs filling specialized indications. AI-driven clinical trial optimization—applying machine learning to site selection, patient recruitment, and protocol design—is a key differentiator that IQVIA's data scale uniquely enables, potentially compressing trial timelines and improving success rates for pharmaceutical clients.
The IQVIA Story
Founders
Company Timeline
Major milestones in IQVIA's journey
Leadership Team
Meet the leaders behind IQVIA
Ari Bousbib
Ari Bousbib has served as chairman and CEO of IQVIA since October 2016, following the merger of Quintiles and IMS Health. He previously served as chairman and CEO of IMS Health from 2010-2016, leading the company's 2014 IPO. Prior to IMS Health, Ari spent 14 years at United Technologies Corporation, serving as president of UTC Commercial Companies with oversight of $36 billion in annual revenues and 150,000 employees. He holds an MS in Mathematics and Structural Engineering from Ecole Superieure des Travaux Publics, Paris, and an MBA in Finance from Columbia University. He serves on the board of The Home Depot and was appointed by the President to the Commission on White House Fellowships in 2008.
Ron E. Bruehlman
Ron Bruehlman has served as CFO since August 2020, bringing 40 years of finance leadership experience across healthcare, industrial, and petroleum industries. He previously served as CFO of IMS Health from July 2011 through September 2016, guiding the company through its 2014 IPO and $16 billion merger with Quintiles. Before IMS Health, Ron had a 23-year career at United Technologies Corporation in senior finance roles. He earned a BS in Economics from the University of Delaware and an MBA in Finance from the University of Chicago Booth School of Business. He serves as Chairman of Q2 Solutions board and as Audit Committee Chair for Atotech Ltd.
Trudy Stein
Trudy Stein serves as EVP and Chief Human Resources Officer, overseeing IQVIA's global human resources strategy and operations. She brings extensive expertise in talent management, organizational development, and employee engagement, leading initiatives that have earned IQVIA recognition as one of Fortune's World's Most Admired Companies. She champions the company's culture of belonging and Employee Resource Groups that support diverse perspectives and experiences.
Jeffrey Spaeder, M.D.
Dr. Jeffrey Spaeder serves as Chief Medical and Scientific Officer, responsible for overseeing IQVIA's medical and scientific strategies. He brings deep clinical and research expertise to guide the company's approach to clinical development, real-world evidence, and healthcare innovation, ensuring scientific rigor across IQVIA's portfolio of services and solutions.
Bhavik Patel
Bhavik Patel leads IQVIA's Commercial Solutions division, overseeing the company's suite of commercial analytics, launch strategy, market access, brand management, and promotional engagement solutions. He is responsible for helping life sciences companies optimize their commercial operations and maximize the value of their products in the marketplace.
Richard Staub
Richard Staub serves as President of Research & Development Solutions, IQVIA's largest business segment representing 55% of company revenue. He oversees the company's clinical research services, including trial design, site operations, patient engagement, and regulatory affairs, managing a contracted backlog exceeding $31 billion.
Rob Kotchie
Rob Kotchie leads IQVIA's Real-World Solutions division, responsible for the company's real-world evidence platforms, healthcare data analytics, and AI-powered patient and HCP profiling solutions. He oversees one of healthcare's largest data repositories with over 1.2 billion de-identified patient health records.
Eric Sherbet
Eric Sherbet serves as EVP, General Counsel and Secretary, providing legal leadership across IQVIA's global operations. He oversees legal, compliance, and regulatory matters for the company's complex multinational operations spanning over 100 countries and highly regulated healthcare and clinical research activities.
Open Positions
Reddit Discussions
Key Differentiators
Market Leader
IQVIA is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $15200M in revenue, IQVIA operates at enterprise scale with proven market validation.
Frequently Asked Questions
Not So Random Others
YouShift
YouShift is a United States-based AI healthcare workforce management platform — building the operating system for healthcare staffing starting with AI-powered scheduling agents that replace the comple
Hermes Robotics
Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Bucket Robotics
Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse auto
Altria
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s
Dusty Robotics
Dusty Robotics is a Mountain View, California-based construction robotics company — backed with $69.5 million in total funding from Root Ventures, Scale Venture Partners, Canaan Partners, GRIDS Capita
Compare IQVIA with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from IQVIA? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim IQVIA Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention IQVIA vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →